Magnesium Silicate Patents (Class 424/683)
  • Patent number: 10159265
    Abstract: The present invention refers to a method for reducing methane production in ruminants comprising administering to said ruminant a feed composition containing a flavanone glycoside.
    Type: Grant
    Filed: April 18, 2013
    Date of Patent: December 25, 2018
    Assignee: INTERQUIM, S.A.
    Inventors: Joaquim Balcells Terés, Francisco Javier Crespo Montero
  • Patent number: 10105320
    Abstract: A soluble fiber lozenge provided herein includes a body that is partially or wholly receivable in an oral cavity. The body includes a soluble-fiber matrix and one or more additives dispersed in the soluble-fiber matrix. In some cases, a soluble fiber lozenge provided herein includes at least 40 weight percent of soluble fiber. In some cases, soluble fiber in soluble fiber lozenge provided herein can include maltodextrin. The soluble fiber lozenge is adapted to release one or more additives from the body when the body is received within the oral cavity of a consumer and exposed to saliva. A method of making soluble fiber lozenges provided herein includes forming a molten mixture of at least 40 weight percent soluble fiber, one or more additives, and less than 15 weight percent water while maintaining a mixture temperature of less than 200° C. and portioning the molten mixture into a plurality of soluble fiber lozenges. In some cases, the ingredients can be mixed to form the molten mixture in an extruder.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: October 23, 2018
    Assignee: ALtria Client Services
    Inventors: Feng Gao, Diane L. Gee, Shuzhong Zhuang, Phillip M. Hulan, William J. Burke, Gerd Kobal
  • Patent number: 9511023
    Abstract: The present invention relates to liquid or semi-solid pharmaceutical compositions, more specifically to aqueous pharmaceutical suspension or semi-solid paste containing natural mineral clays as active ingredients. These compositions are particularly useful for the treatment of acute and chronic diarrhea.
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: December 6, 2016
    Assignee: IPSEN PHARMA S.A.S.
    Inventors: Béatrice Hacher, Didier Kubiak, Jeremiah Harnett, Nathalie Mondoly
  • Patent number: 9462811
    Abstract: Methods of improving the growth of a plant by applying a plant growth effective amount of a plant growth composition that includes a hydrated aluminum-magnesium silicate and at least one dispersant selected from the group consisting of a sucrose ester, a lignosulfonate, an alkylpolyglycoside, a naphthalenesulfonic acid formaldehyde condensate and a phosphate ester to plant propagation material in the absence of insect pest pressure.
    Type: Grant
    Filed: March 6, 2015
    Date of Patent: October 11, 2016
    Assignee: FMC Corporation
    Inventors: Timothy M. Martin, Frank Zawacki
  • Patent number: 9101565
    Abstract: The present invention relates to a method for the preparation of a tablet comprising at least 50% w/w of calcium carbonate, the method comprising i) providing a particulate composition comprising a) calcium carbonate, b) a binding sugar alcohol selected from sorbitol or isomalt, or combinations thereof, c) a non-binding sugar alcohol selected from mannitol, maltitol or xylitol, or combinations thereof, and ii) compressing said composition using a tabletting machine equipped with at least one pair of punches and dies, wherein the pair of punches and die before filling the die with said particulate composition is sprayed with a composition comprising a lubricant selected from magnesium stearate, calcium stearate or stearic acid or combinations thereof.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: August 11, 2015
    Assignee: TAKEDA NYCOMED AS
    Inventors: Peder Mohr Olsen, Poul Egon Bertelsen, Thomas Thisted, Henrik Ravn Aage
  • Patent number: 9040094
    Abstract: The present invention has an object to provide a flaky particulate material giving skin an excellent smoothness, which is free from whitening problem upon use thereof owing to its high transparency. The present invention also has another object to provide a cosmetic composition containing the flaky particulate material. The present invention relates to flaky particulate material, which has an average coefficient of friction is not more than 0.50, and a total light transmittance is not less than 85%. A particle in the flaky particulate material comprises a substrate particle made of one material selected from the group consisting of mica, a synthetic mica, sericite, talc, barium sulfate and aluminum oxide. The present invention provides a flaky particulate material that gives skin excellent smoothness, a natural tone, and a matt appearance. The flaky particulate material of the present invention gives a cosmetic composition which provides great comfort of use, and an excellent appearance.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: May 26, 2015
    Assignee: Sakai Chemical Industry Co., Ltd.
    Inventors: Keiji Ono, Takuro Ashida, Hiroyuki Izumikawa, Hirobumi Yoshida
  • Patent number: 8993484
    Abstract: Methods of improving the growth of a plant by applying a plant growth effective amount of a plant growth composition that includes a hydrated aluminum-magnesium silicate and at least one dispersant selected from the group consisting of a sucrose ester, a lignosulfonate, an alkylpolyglycoside, a naphthalenesulfonic acid formaldehyde condensate and a phosphate ester to plant propagation material in the absence of insect pest pressure.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: March 31, 2015
    Assignee: FMC Corporation
    Inventors: Timothy M. Martin, Frank Zawacki
  • Patent number: 8956664
    Abstract: The present disclosure relates generally to the field of mucositis. More particularly, methods and compositions for treating, ameliorating and/or preventing mucositis are provided by administering a clay to the subject in need.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: February 17, 2015
    Assignee: Salient Pharmaceuticals Incorporated
    Inventor: Richard M. Scruggs
  • Publication number: 20150017144
    Abstract: Provided herein are compositions useful for the treatment or prevention of C. difficile-associated disease or C. difficile-associated diarrhea in a subject in need thereof, and delivery systems and package systems comprising the same. Also provided are methods using the compositions, delivery systems, package systems and methods of making the same.
    Type: Application
    Filed: July 10, 2014
    Publication date: January 15, 2015
    Inventors: Mark Herthel, Erin Kelley, Tara Hembrooke, Chase Millhollen
  • Patent number: 8926710
    Abstract: Osteoconductive bone graft materials are provided. These compositions contain injectable cements and demineralized bone matrix fibers. The combination of these materials enables the filling of a bone void while balancing strength and resorption.
    Type: Grant
    Filed: October 25, 2010
    Date of Patent: January 6, 2015
    Assignee: Warsaw Orthopedic, Inc.
    Inventor: William F. McKay
  • Publication number: 20140377354
    Abstract: The subject of the present invention is a flavoured therapeutic composition containing a clay as the active principle, and characterized in that the clay is a dioctahedral smectite and the flavour is encapsulated.
    Type: Application
    Filed: February 12, 2014
    Publication date: December 25, 2014
    Applicants: FIRMENICH S.A., IPSEN PHARMA S.A.S.
    Inventors: Jérôme BARRA, Denis LE HAZIF
  • Publication number: 20140308337
    Abstract: Hemostatic compositions comprising a wet layered clay (e.g., wet kaolin) and, optionally, a zeolite, as well as devices and methods of use to promote blood clotting, are provided.
    Type: Application
    Filed: March 5, 2014
    Publication date: October 16, 2014
    Applicant: The Regents of the University of California
    Inventors: Sarah Baker, April Sawvel, Galen D. Stucky
  • Publication number: 20140271610
    Abstract: The present invention relates to composition(s) comprising collagen, calcium ions and alginate, wherein the composition polymerizes in situ when contacted with blood. The composition may further comprise an erythrocyte aggregation agent and/or a platelet activation agent. The composition may be formulated into two separate formulations. The first formulation comprises collagen in a calcium-containing solution and a second formulation comprises an aqueous alginate solution. The two formulations can be mixed prior to the contact with blood or mixed coincident with the contact with blood.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 18, 2014
    Applicant: ORTHOVITA, INC.
    Inventor: James San Antonio
  • Patent number: 8790668
    Abstract: The present invention relates to a personal care composition that contains a rinse-off composition which deposits at least 0.5 ?g/cm2 of shiny particles on the skin. Preferably, the shiny particles are hydrophobically modified interference pigments. The inventors have found that hydrophobically modifying the particles significantly improves the deposition of the particles on skin from rinsable compositions.
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: July 29, 2014
    Assignee: The Procter & Gamble Company
    Inventors: Mannie Lee Clapp, Cynthia Ann Garza, Qing Stella, Paul Robert Tanner, Rebecca Ann Taylor
  • Patent number: 8769868
    Abstract: The invention relates to a microbial biomass composition produced from a heterotrophic fermentation whose fatty acid profile exhibits: an eicosapentaenoic acid (EPA) to arachidonic acid (ARA) ratio of about 11:1 or more; an EPA to total co-concentrating fatty acid ratio of about 8:1 or more, extract compositions, and methods of producing such compositions.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: July 8, 2014
    Assignee: Photonz Corporation Limited
    Inventors: Hywel David Griffiths, Karl Thomas Geiringer, Mark Humphrey Dines
  • Publication number: 20140099373
    Abstract: The present invention relates to a combination of an anti-toxin, The present invention relates to a combination of an anti-toxin, an immunomodulator and a component that provides energy to mucosal cells, which may be useful for decreasing effects of Clostridia sp.
    Type: Application
    Filed: October 2, 2013
    Publication date: April 10, 2014
    Applicant: Oil-Dri Corporation of America
    Inventors: Jonathan Broomhead, Fang Chi, Ron Cravens, George Robert Goss, Richard Jaffee, Sara LeAnn Johnston, Michael McPherson, Ronda Jean Williams
  • Patent number: 8637091
    Abstract: The present invention provides a composition comprising functional mineral that is substantially free of crystalline silica. The agricultural particle film composition may be applied to horticultural plants and animals.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: January 28, 2014
    Assignee: Tessenderlokerley Inc
    Inventors: Richard C. Pluta, John T. Mosko
  • Publication number: 20130302412
    Abstract: Compositions containing therapeutically effective amounts of transfer factor and one or more compounds selected from glucosamine salts, dimethyl glycine, chondroitin, montmoril-lonite, curcumin, hyaluronic acid, boswellic acid, superoxide dismutase, methyl sulfonyl methane and glucans. Methods of treating inflammation and arthritis with the compositions of the present invention are also disclosed.
    Type: Application
    Filed: March 15, 2013
    Publication date: November 14, 2013
    Inventor: Joseph C. Ramaekers
  • Publication number: 20130295022
    Abstract: The present invention provides a highly tolerable, hydrating lanolin containing foamable composition for administration to the skin, body surface, body cavity or mucosal surface, e.g., the mucosa of the nose, mouth, eye, ear, respiratory system, vagina or rectum. The foamable composition includes lanolin, a surface-active agent, about 0.01% to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent, water, and a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.
    Type: Application
    Filed: June 6, 2013
    Publication date: November 7, 2013
    Inventors: Doron Friedman, Alex Besonov, Dov Tamarkin, Meir Eini
  • Publication number: 20130238065
    Abstract: A phase change formulation includes a reversible phase change material and a thermal conductivity additive formulated for application to a user's epidermis.
    Type: Application
    Filed: March 6, 2012
    Publication date: September 12, 2013
    Applicant: EXERT CO.
    Inventor: Arvind M. Rao
  • Publication number: 20130209378
    Abstract: A cosmetic agent that takes the place of powdered talc is described herein. The present cosmetic agent is a skin conditioning and lubricating crème comprising talc; at least one volatile silicone fluid; at least one structuring component; and at least one emollient. The inventive composition provides skin conditioning and lubrication without the inconveniences inherent in using powdered products such as talcum powder.
    Type: Application
    Filed: February 9, 2012
    Publication date: August 15, 2013
    Applicant: The Dial Corporation
    Inventors: Jennifer Harris, Debra K. Butterworth
  • Patent number: 8506938
    Abstract: A compound applying to skin and a method making the same comprises certain proportions for following first components: Dimethicone Crosspolymer, Dimethicone/Vinyl Dimethicone Crosspolymer, Cyclotetrasiloxane, Dimethicone, Cetyl PEG/PPG-15/15 Butyl Ether Dimethicone, Squalane, and Titanium Dioxide. Second components, third components, and fourth components with specific proportions as claimed are timely added in the first components. Sequentially mixing, heating, and dissolving the afore components would bring about the compound that keeps skin from sun exposure and provides functions of moisturizing, anti-wrinkle, spots clearing, blushers, anti-acnes, and whitening.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: August 13, 2013
    Inventor: Hsien-wen Lin
  • Publication number: 20130189378
    Abstract: Methods and compositions for modifying an individual's perception of an interval of time are disclosed.
    Type: Application
    Filed: January 4, 2013
    Publication date: July 25, 2013
    Inventor: Alan R. Hirsch
  • Publication number: 20130101645
    Abstract: The present disclosure relates generally to the field of mucositis. More particularly, methods and compositions for treating, ameliorating and/or preventing mucositis are provided by administering a clay to the subject in need.
    Type: Application
    Filed: October 22, 2012
    Publication date: April 25, 2013
    Applicant: Salient Pharmaceuticals Incorporated
    Inventor: Salient Pharmaceuticals Incorporated
  • Publication number: 20130101643
    Abstract: The present disclosure relates generally to the field of proctitis. More particularly, methods and compositions for treating, ameliorating and/or preventing proctitis are provided.
    Type: Application
    Filed: October 19, 2012
    Publication date: April 25, 2013
    Applicant: Salient Pharmaceuticals Incorporated
    Inventor: Salient Pharmaceuticals Incorporated
  • Publication number: 20130095183
    Abstract: The bone graft system comprises a solid inorganic component, which is bone graft material, and a hydrogel. The hydrogel contains >2 ppm of silicon ions, calculated as parts by weight of Si per million of the aqueous component of the hydrogel. Preferably, the solid inorganic component comprises hydroxyapatite or a silicon-containing hydroxyapatite, and may be a silicon-containing hydroxyapatite having a Ca/P ratio in the range 2.05 to 2.55 and a Ca/(P+Si) molar ratio less than 1.66. Bone healing is promoted by delivery of silicon ion release from the hydrogel and by the solid inorganic component stimulating cell behavior.
    Type: Application
    Filed: June 22, 2011
    Publication date: April 18, 2013
    Inventors: Iain Ronald Gibson, Janet Mabel Scott Skakle, Jordan Christopher Conway, Basil Annaz
  • Patent number: 8409629
    Abstract: A hemostatic agent composition that includes a clay hemostatic agent which is inert and non-reactive relative to blood clotting proteins and platelets, yet is capable of accelerating the formation of a stable clot when applied to an actively bleeding wound.
    Type: Grant
    Filed: August 14, 2008
    Date of Patent: April 2, 2013
    Inventors: Jack Mentkow, Lisa Mentkow
  • Patent number: 8388984
    Abstract: Compositions which deliver adsorbents, alone or in combination with active drug “degrading molecules,” in a site-specific manner to the intestine, and which eliminate or at least lower the concentration of residual unwanted material within the intestine, and methods of treatment using the compositions, are disclosed. The compositions are ideally designed to specifically release the adsorbents in a programmed manner at a specific site of the intestinal tract. Programmed delivery prevents adsorbents from interfering with the normal absorption process of a given molecule after oral absorption, until it reaches the lower part of the small intestine. The compositions can be used to adsorb, and therefore remove, any residual drug, metabolite thereof, or bacterial toxin after oral or parenteral administration which would otherwise cause adverse effects in the lower intestine and/or colon.
    Type: Grant
    Filed: September 14, 2011
    Date of Patent: March 5, 2013
    Assignees: Da Volterra, Centre National de la Recherche Scientifique, Assistance Publique—Hopitaux de Paris, Universite Paris Diderot—Paris 7, Universite Paris-SUD 11
    Inventors: Helene-Celine Huguet, Antoine Andremont, Nicolas Tsapis, Elias Fattal
  • Publication number: 20130039953
    Abstract: A method for treating a surface with a therapeutic agent is disclosed. The method comprises precipitating a therapeutic agent from a hydrophilic polymeric base layer with which the therapeutic agent has been complexed, to form a layer comprising microparticles of the therapeutic agent on the hydrophilic polymeric base layer, the hydrophilic polymeric base layer being grafted to the surface. Devices comprising a surface having a hydrophilic polymeric base layer comprising a hydrophilic polymer grafted to the surface and a layer comprising microparticles of a therapeutic agent disposed on and complexed with the hydrophilic polymeric base layer are also disclosed.
    Type: Application
    Filed: July 6, 2012
    Publication date: February 14, 2013
    Applicant: Covalon Technologies
    Inventors: Vyacheslav Dudnyk, Valerio DiTizio
  • Publication number: 20130039999
    Abstract: The invention relates to the use of a clay for the preparation of a medicament for treating coeliac disease. Preferably, the clay used is of smectite type.
    Type: Application
    Filed: April 13, 2012
    Publication date: February 14, 2013
    Applicant: IPSEN PHARMA S.A.S.
    Inventor: Hélène MATHIEX-FORTUNET
  • Publication number: 20130004580
    Abstract: Compositions and methods for treating and/or preventing conditions such as diaper rash and atopic dermatitis are disclosed. The compositions and methods are particularly useful in the treatment and prevention of diaper rash and diaper dermatitis caused by the prolonged contact of human skin with body waste. The methods employ the topical application of a trypsin-inhibiting agent to the area in need of such treatment, or the area where prevention is desired. The trypsin-inhibiting agent is preferably a specified divalent cation, i.e., magnesium, in combination with talc.
    Type: Application
    Filed: June 28, 2011
    Publication date: January 3, 2013
    Inventors: Connie B. Lin, Euen Thomas Graham Ekman Gunn, Ya-Ping Hu, Neema Kulkarni, Mary Catherine Mack
  • Patent number: 8303941
    Abstract: A composition comprising mineral water and a chelating agent present in an amount sufficient to maintain all of the minerals in the water in solution. The mineral water is preferably obtained from Mount Clemens, Mich., US, and is preferably chelated with an ammonium and/or a sodium salt of an acid selected from the group consisting of ethylenediaminetetraacetic acid, nitrilotetraacetic acid, ?-alaninediacetic acid, ethylenediaminosuccinic acid, aminotrimethylenephosphoric acid, serinediaacetic acid, asparaginediacetic acid, methylgylcinediacetic acid and mixtures thereof. The resultant chelated mineral water may be combined with a cosmetically acceptable skin-conditioning agent and a cosmetically acceptable topical carrier, thereby resulting in a cosmetic composition that will confer beneficial effects on the skin, e.g., softening, hydrating and healing effects.
    Type: Grant
    Filed: April 19, 2008
    Date of Patent: November 6, 2012
    Assignee: Geologix, Inc.
    Inventor: Stephen Musumeci
  • Patent number: 8273380
    Abstract: A beverage for minimizing or reducing jet lag symptoms preferably includes vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin D, zinc, calcium, iodine, magnesium, manganese, ginseng, ginkgo biloba, grape seed extract, Echinacea extract and water. A method for minimizing or reducing jet lag symptoms including ingestion of the beverage by a traveler, one hour prior to a flight, and/or during the flight, and/or after a flight.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: September 25, 2012
  • Publication number: 20120107367
    Abstract: Compositions which deliver adsorbents, alone or in combination with active drug “degrading molecules,” in a site-specific manner to the intestine, and which eliminate or at least lower the concentration of residual unwanted material within the intestine, and methods of treatment using the compositions, are disclosed. The compositions are ideally designed to specifically release the adsorbents in a programmed manner at a specific site of the intestinal tract. Programmed delivery prevents adsorbents from interfering with the normal absorption process of a given molecule after oral absorption, until it reaches the lower part of the small intestine. The compositions can be used to adsorb, and therefore remove, any residual drug, metabolite thereof, or bacterial toxin after oral or parenteral administration which would otherwise cause adverse effects in the lower intestine and/or colon.
    Type: Application
    Filed: September 14, 2011
    Publication date: May 3, 2012
    Inventors: Helene-Celine Huguet, Antoine Andremont, Nicolas Tsapis, Elias Fattal
  • Publication number: 20120016347
    Abstract: Apparatus and methods for significant reduction of seroma formation, seroma related complications and time until drain removal following surgery are disclosed. Talc, with and without thrombin, bleomycin, erythromycin, tetracycline, doxycycline, polidocanol alone or in combination or combined with talc and/or thrombin for use in operatives wound and lymph node dissections to reduce seromas are disclosed.
    Type: Application
    Filed: July 13, 2010
    Publication date: January 19, 2012
    Inventors: John I. Shipp, B. Todd Heniford
  • Publication number: 20120003328
    Abstract: Provided are a modified Na-montmorillonite and a preparation method thereof, wherein the content of Na+ in the modified sodium-montmorillonite, calculated as Na2O, is not less than 2.0%. The modified Na-montmorillonite has more reasonable microstructure, higher performance, and better quality. Also provided are a method for preparing a modified nanometered Na-montmorillonite from the modified Na-montmorillonite, and the modified nanometered Na-montmorillonite obtained by the method. Also provided are uses and a pharmaceutical composition of the modified Na-montmorillonite or modified nanometered Na-montmorillonite.
    Type: Application
    Filed: January 8, 2010
    Publication date: January 5, 2012
    Inventors: Haihui Zheng, Guanglie Lv, Zhiguo Xia, Nian Xu, Sheng Le, Zhongchao Ma, Yufeng Chi, Wenbo Chen, Jixin Chen
  • Patent number: 8029827
    Abstract: Insecticidal compositions suitable for use in preparation of insecticidal liquid fertilizers comprising a pyrethroid, a hydrated aluminum-magnesium silicate, and at least one dispersant selected from the group consisting of a sucrose ester, a lignosulfonate, an alkylpolyglycoside, a naphthalenesulfonic acid formaldehyde condensate and a phosphate ester are disclosed.
    Type: Grant
    Filed: May 11, 2006
    Date of Patent: October 4, 2011
    Assignee: FMC Corporation
    Inventor: Timothy Martin
  • Publication number: 20110142910
    Abstract: Disclosed are optimized keratin preparations for use in medical applications. Methods to produce optimized keratin preparations are provided for use in biomedical applications, particularly for the treatment of bleeding, and for the treatment of wounds. Also disclosed are surgical or paramedic aids comprising a substrate with keratin preparations provided thereon, and kits comprising keratin derivatives packaged in sterile form.
    Type: Application
    Filed: February 16, 2007
    Publication date: June 16, 2011
    Inventor: Mark E. Van Dyke
  • Patent number: 7955610
    Abstract: The present invention provides an antimicrobial composition for topical application, preferably for treating acne, and a method for using the composition. The composition comprises a photocatalyst mixture comprising a photocatalyst, such as titanium dioxide, and sodium perborate, magnesium silicate, and citric acid. The photocatalyst mixture is in an amount effective as an antimicrobial under visible light. The method comprises applying the composition to a target area of the skin and exposing the area to visible light.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: June 7, 2011
    Assignees: National Science and Technology Development Agency, Nonami Science (Thailand) Co., Ltd.
    Inventors: Wiwut Tanthapanichakoon, Uracha Rungsardthong, ML Sumarn Saraya, Wasana Thaitae
  • Patent number: 7910136
    Abstract: The present invention relates to a method of treating osteoarthritis by administering a mineral composition in the form of a nutritional supplement, where the mineral composition may contain Smectite, Gypsum, Quartz, Feldspar, Jarosite, Kaolinite and/or Zeolite.
    Type: Grant
    Filed: August 7, 2008
    Date of Patent: March 22, 2011
    Assignee: Sierra Mountain Minerals, Inc.
    Inventor: Michael Bentley
  • Publication number: 20100303931
    Abstract: A subject-matter of the present invention is a cosmetic composition expanded in volume, in the form of an oil-in-water emulsion, comprising an internal fatty phase and an external aqueous phase comprising at least one inulin modified by hydrophobic chains and at least two gelling agents for the aqueous phase, one of the two gelling agents being chosen from unmodified clays, in particular montmorillonites, hectorites, smectites, bentones or laponites, or cellulose polymers, such as hydroxyethylcellulose, hydroxypropylcellulose, methylcellulose, ethylhydroxyethylcellulose, carboxymethylcellulose and quaternized cellulose derivatives, and the other gelling agent being chosen from gums arabic, guar gum, xanthan derivatives, karaya gum or locust bean gum, the said internal fatty phase being present in a content ranging from 5 to 50% by weight.
    Type: Application
    Filed: May 6, 2008
    Publication date: December 2, 2010
    Applicant: L'Oreal
    Inventors: Charlotte Feltin, Florence Dop
  • Patent number: 7842284
    Abstract: A regimen for hunting includes using a number of zeolite-containing personal items in connection with a hunter's apparel and body to reduce the hunter's scent for improved hunting. The personal items include mouthwash, deodorant/anti-perspirant, body and boot powder, bar and liquid soap for cleansing the body and hair, laundry detergent and dryer sheets. Each of the personal items includes an effective amount of zeolite, so that use of the personal items reduces the available scent to be detected by animals in the wild. The regimen can also include the use of a seat cushion that is covered with an activated carbon-containing fabric for odor control and/or elimination.
    Type: Grant
    Filed: September 17, 2007
    Date of Patent: November 30, 2010
    Assignee: Johnson Laboratories, Inc.
    Inventor: Louis B. Johnson
  • Publication number: 20100297191
    Abstract: The invention relates to the use of a cleansing and/or care composition for impregnating a pile of absorbent supports. The care and cleansing composition has a relatively high apparent viscosity while having a rheological behavior of the shear-thinning and thixotropic type and comprises at least one care and/or cleansing compound. Thus, during an impregnation under stress, especially under pressure and with prior stirring, the composition becomes sufficiently fluid to enable it to rapidly and homogeneously diffuse into the supports arranged in a pile.
    Type: Application
    Filed: October 17, 2008
    Publication date: November 25, 2010
    Applicant: GEORGIA-PACIFIC FRANCE
    Inventors: Anne-Gaelle Clermont, Jocelyne Florence, Bruno Bret
  • Publication number: 20100291239
    Abstract: The invention refers to the use of a mixture of naringin, bitter orange extract and sepiolite to improve ruminal fermentation in ruminants.
    Type: Application
    Filed: January 8, 2009
    Publication date: November 18, 2010
    Inventors: Maria del Mar Serra, Fernando Heredia, Francisco Javier Crespo, Joaquim Balcells
  • Publication number: 20100233222
    Abstract: Cosmetic treatment processes include application of cosmetic compositions to a skin surface by spraying, such compositions including at least one filler in a physiologically acceptable medium, the at least one filler giving the composition a haze index H of 40% or more and a hemispheric transmission factor Th of 70% or more.
    Type: Application
    Filed: May 25, 2010
    Publication date: September 16, 2010
    Applicant: L'OREAL
    Inventors: Franck GIRIER DUFOURNIER, Anne Liechty
  • Patent number: 7790202
    Abstract: A multi-purpose skin composition which functions as a sunscreen, an anti-perspirant, an insect/pest repellant and/or an antiseptic is disclosed. In some illustrative embodiments, the multi-purpose skin composition includes a powdered repellent formulation having a substantially homogenous powdered mixture including corn starch powder, zinc oxide powder, peppermint powder, basil powder, rosemary powder, eucalyptus powder, copper mica powder and silica powder spheres. In other illustrative embodiments, the multi-purpose skin composition includes a powdered relief formulation having a substantially homogenous powdered mixture comprising corn starch powder, lavender powder, peppermint powder, eucalyptus powder and silica powder spheres.
    Type: Grant
    Filed: April 9, 2007
    Date of Patent: September 7, 2010
    Inventor: Helen D. Martell
  • Publication number: 20100189683
    Abstract: This invention relates to pulsatile dose administration of gossypol or pharmaceutical compositions thereof for treating diseases, disorders and conditions responsive to gossypol, inhibiting the activity of anti-apoptotic Bcl-2 family proteins, inducing apoptosis in cells and increasing the sensitivity of cells to inducers of apoptosis.
    Type: Application
    Filed: December 10, 2009
    Publication date: July 29, 2010
    Applicant: Ascenta Therapeutics, Inc.
    Inventors: Jon T. Holmlund, Mel Sorensen, Lance Leopold, Dajun Yang
  • Publication number: 20100158825
    Abstract: The invention provides for cosmetic and personal care compositions comprising a synthetic magnesium aluminosilicate clay. The synthetic magnesium aluminosilicate clay is formed at ambient pressure by a series of reaction steps and a pH change from acidic pH to basic pH. The characteristics of the magnesium aluminosilicate clay, including platelet size, degree of stacking, and porosity can be tuned depending on the cosmetic or personal care product desired. In addition, these cosmetic and personal care compositions optionally include one or more of the following components: odor controlling agents, skin protectants, diluents, lipophilic skin health benefit agents, sunscreens, humectants, emollients, slip compounds, and moisturizers.
    Type: Application
    Filed: December 18, 2008
    Publication date: June 24, 2010
    Inventors: Theodorus Maesen, Alexander E. Kuperman, Ibrahim J. Uckung
  • Publication number: 20100098780
    Abstract: The present invention has an object to provide a flaky particulate material giving skin an excellent smoothness, which is free from whitening problem upon use thereof owing to its high transparency. The present invention also has another object to provide a cosmetic composition containing the flaky particulate material. The present invention relates to flaky particulate material, which has an average coefficient of friction is not more than 0.50, and a total light transmittance is not less than 85%. A particle in the flaky particulate material comprises a substrate particle made of one material selected from the group consisting of mica, a synthetic mica, sericite, talc, barium sulfate and aluminum oxide. The present invention provides a flaky particulate material that gives skin excellent smoothness, a natural tone, and a matt appearance. The flaky particulate material of the present invention gives a cosmetic composition which provides great comfort of use, and an excellent appearance.
    Type: Application
    Filed: February 13, 2007
    Publication date: April 22, 2010
    Applicant: SAKAI CHEMICAL INDUSTRY CO., LTD.
    Inventors: Keiji Ono, Takuro Ashida, Hiroyuki Izumikawa, Hirobumi Yoshida
  • Publication number: 20100003348
    Abstract: The invention relates to the use of a clay for the preparation of a medicament for treating coeliac disease. Preferably, the clay used is of smectite type.
    Type: Application
    Filed: February 6, 2008
    Publication date: January 7, 2010
    Applicant: IPSEN PHARMA S.A.S.
    Inventor: Héléne Mathiex-Fortunet